About
Sepsis Diagnostics
Molecular Detection is developing SEPSIS-xxpress, a hospital-based instrument for rapid sepsis diagnosis and pathogen profiling. SEPSIS-xxpress provides doctors with the specific pathogen and antibiotic-resistance profile necessary to treat infection in the critical early hours. The SEPSIS-xxpress system comprises an instrument platform with embedded touchscreen computer and test kits with single-use, disposable cartridges pre-loaded with all needed reagents. Hospital staff cansimply draw a patient's blood sample, insert the vacutainer into a test cartridge, and start the test. The comprehensive diagnosis is then presented on-screen in less than threehours.
Identity
| Name | Molecular Detection |
|---|---|
| Slug | molecular-detection |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6n6JkLDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Oct 2016 |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | E.S. Artom Street 10, Jerusalem, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
doctorsmedical-technologieshospitalsinflammatory-diseasesdiagnosticsdecision-makingblood-testearly-detection
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}